Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

10.60
Delayed Data
As of Feb 12
 -0.65 / -5.78%
Today’s Change
10.46
Today|||52-Week Range
30.37
-44.99%
Year-to-Date
No recent news for Flexion Therapeutics Inc.

Today’s Trading

Previous close11.25
Today’s open11.53
Day’s range10.46 - 11.53
Volume331,712
Average volume (3 months)170,395
Market cap$228.3M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+91.44%
Earnings growth (this year)-6.77%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...0.000.00%
BSTCBiospecifics Technol...+1.99+5.91%
ARWRArrowhead Research C...+0.06+1.82%
ENZEnzo Biochem Inc-0.07-1.60%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$0.00
Annual profit (last year)-$27.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Chief Financial Officer
Frederick W. Driscoll
Corporate headquarters
Burlington, Massachusetts

Forecasts

Partner Offers